Hubungan IL-8 Dengan Gastritis H.Pylori dan Non H.Pylori
DAFTAR PUSTAKA
1. El-Zimaity HMT. Recent advances in the histopathology of gastritis.
Current Diagnostic Pathology: 2007; 13:340-8.
2. Rugge M, Genta RM. Staging and grading of chronic gastritis. Human
pathology: 2005; 36:228-33.
3. Fox JG, Wang TC. Inflammation, atrophy and gastric cancer. The Journal
of Clinical Investigation: 2007; 17:60-9.
4. Cesar ACG, Cury PM, Payao SLM. Comparison of histological and
molecular diagnosis of Helicobacter pylori in benign lesions and gastric
adenocarcinoma. Braz J Microbiol: 2005; 36(1):261-6.
5. Rehnberg-Laiho L, Rautelin H, Koskela P, Sarna S, Pukkala E, Aromaa A,
et al. Decreasing prevalence of helicobacter antibodies in Finland, with
reference to the decreasing incidence of gastric cancer. Epidemiol Infect:
2001; 126:37-42.
6. Matsukura N, Yamada S, Kato S, Tomtitchong P, Tajiri T, Miki M, et al.
Genetic differences in interleukin-1 betapolymorphisms among four Asian
populations: an analysis of the Asian paradox between H. pylori infection
and gastric cancer incidence. J Exp Clin Cancer Res: 2003; 22: 47-55.
7. Xuan J, Deguchi R, Yanagi H, Ozawa H, Urano T, Ogawa Y, et al.
Relationship between gastric mucosal IL-8 levels and histological gastritis
in patients with Helicobacter pylori infection. Tokai J Exp Clin Med:
2005; 30(2):83-8.
8. Andersen LP, Holck S, Janulaityte-Gu¨nther D, Kupcinskas L, Kiudelis G,
Jonaitis L, et al. Gastric inflammatory markers and interleukins in patients
with functional dyspepsia, with and without Helicobacter pylori infection.
FEMS Immunology and Medical Microbiology: 2005; 44:233–8.
9. Toljamo K. Gastric erosions – clinical significance and pathology. A longterm follow-up study. University of Oulu, Finland:Acta Univ Oul: 2012:
hlm 1-80.
10. S. Ilyas. Repository. Usu.ac.id 2013
11. Dixon MF, Genta RM, Yardley H, Correa P. Classification and grading of
gastritis: the updated Sydney system. Am J Surg Pathol. 1996;20:1161–81.
12. Aydin O, Egilmez R, Karabacak T, Kanik A. Interobserver variation in
histopathological assessment of Helicobacter pylori gastritis.World J
Gastroenterol. 2003; 9: 2232-5.
13. Szoke D. Genetic factors related to the histological and macroscopic
lesions of the stomach. [disertasi]. Budapest: Semmelweis University;
2009. Hlm 7-61.
14. Guindy AE, Ghoraba H. A study of the concordance between endoscopic
gastritis and histological gastritis in nonulcer dyspeptic patients with and
without Helicobacter pylori infection. Tanta Medical Sciences Journal.
2007;2(2):67-82.
15. Adibi
P.
Gastritis.
[Diunduh
19
Mei
2014].
Tersedia
dari:
http://med.mui.ac.ir
16. Wehbi M, Acute gastritis Medscape. 2014
17. Simadibrata M. Dyspepsia and Gastroesophageal Reflux Disease (GERD):
Is There Any Correlation? Acta Med Indones. 2009; 41(4): 222-7.
18. Silva MIG, de Sousa FCF. Gastric ulcer etiology. In: Chai J, editor. Peptic
Ulcer Disease. Shanghai: Intech; 2011. hlm. 3-28.
19. Loyd RA, McClellan DA. Update on the evaluation and management of
functional dyspepsia. Am Fam Physician. 2011;83(5):547-52.
20. Mueller A, Merrel DS, Grimm J, Falkow S. Profiling of microdissected
gastric epithelial cells reveals a cell-type specific response to Helicobacter
pylori infection. Gastroenterology. 2004;127:1446–62.
21. Syam AF, Sadikin M, Wanandi SI, Rani AA. Molecular mechanism on
healing process of peptic ulcer. Acta Med Indones. 2009;41(2):95-8.
22. Brzozowski T, Konturek PC, Konturek SJ, Brzozowska I, Pawlik T. Role
of prostaglandins in gastroprotection and gastric adaptation. Journal of
physiology and pharmacology. 2005; 56(Suppl 3):33-55.
23. Blaser MJ. Who are we? Indigenous microbes and the ecology of human
disease. EMBO Reports. 2006;7(10): 956–60.
24. Fischer W, Puls J, Buhrdorf R, Gebert B, Odenbreit S, Haas R. Systematic
mutagenesis of the Helicobacter pylori cag pathogenicity island: essential
genes for CagA translocation in host cells and induction of interleukin-8.
Mol Microbiol. 2001; 42:1337-48.
25. Holck S, Norgaard A, Bennedsen M, Permin H, Norn S, Andersen LP, et
al. Gastric mucosal cytokine responses in Helicobacter pylori-infected
patients with gastritis and peptic ulcers. Association with inflammatory
parameters and bacteria load. FEMS Immunology and Medical
Microbiology. 2003;36:175-80.
26. Farinati F, Cardin R, Russo VM, Busatto G, Franco M, Rugge M.
Helicobacter pylori CagA status, mucosal oxidative damage and gastritis
phenotype: a potential pathway to cancer? Helicobacter. 2003; 8:227-34.
27. Farinati F, Cardin R, Russo VM, Busatto G, Franco M, Rugge M.
Helicobacter pylori CagA status, mucosal oxidative damage and gastritis
phenotype: a potential pathway to cancer? Helicobacter. 2003; 8:227-34.
28. Kusters JG, van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter
pylori infection. Clin Microbiol Rev. 2006; 19:449-90.
29. Pelicic V, Reyrat JM, Sartori L, Pagliaccia C, Rappuoli R, Telford JL, et
al.
Helicobacter pylori VacA cytotoxin associated with the bacteria
increases epithelial permeability independently of its vacuolating activity.
Microbiology. 1999;145(8): 2043-50.
30. Sundrud MS, Torres VJ, Unutmaz D, Cover TL. Inhibition of primary
human T cell proliferation by Helicobacter pylori vacuolating toxin
(VacA) is independent of VacA effects on IL-2 secretion. Proc Natl Acad
Sci U S A. 2004;101:7727-32.
31. Zhang Z, Zheng Q, Chen X, Xiao S, Liu W, Lu H. The Helicobacter
pylori duodenal ulcer promoting gene, dupA in China. BMC
Gastroenterol. 2008;8:49-54.
32. Lu H, Hsu PI, Graham DY, Yamaoka Y. Duodenal ulcer promoting gene
of Helicobacter pylori. Gastroenterology. 2005;128:833-48.
33. Yamaoka Y, Kodama T, Kita M, Imanishi J, Kashima K, Graham DY.
Relation between cytokines and Helicobacter pylori in gastric cancer.
Helicobacter. 2001;6(2):116-24.
34. Rad R, Gerhard M, Lang R, Schoniger M, Rosch T, Schepp W, et al. The
Helicobacter pylori blood group antigen-binding adhesin facilitates
bacterial colonization and augments a nonspecific immune response. J
Immunol. 2002;168: 3033-41.
35. Montecucco C, de Bernard M. Molecular and cellular mechanisms of
action of the vacuolating cytotoxin (VacA) and neutrophil-activating
protein (HP-NAP) virulence factors of Helicobacter pylori. Microbes
Infect. 2003;5:715-21.
36. Banerjee A, Mukhopadhyay AK, Paul S, Bhattacharyya A and Swarnakar
S. Unveiling the Intricacies of Helicobacter pylori-induced Gastric
Inflammation: T Helper cells and Matrix Metalloproteinases at a
Crossroad. In: Mozsik G, editor. Current Topics in Gastritis. Croatia:
InTech Publishers; 2013. Chapter 7.
37. Zakaria Z, Devaney RJ, Atherthon JC, Robinson K. Effects of interleukin10 on the gastric epithelial cell response to Helicobacter pylori. In 8th
International Workshop on Pathogenesis and Host Response in
Helicobacter Infections, 5th July, Helsingor, Denmark; 2008.hlm. HP-76.
38. Lew E. Peptic ulcer disease. In: Greenberger NJ, editor. Current Diagnosis
and Treatment Gastroenterology, Hepatology, and Endoscopy. New York:
McGraw Hill; 2009.hlm.175-83.
39. Farinati F, Cardin R, Russo VM, Busatto G, Franco M, Rugge M.
Helicobacter pylori CagA status, mucosal oxidative damage and gastritis
phenotype: a potential pathway to cancer? Helicobacter. 2003; 8:227-34.
40. Eaton KA, Mefford M, Thevenot T. The role of T cell subsets and
cytokines in the pathogenesis of Helicobacter pylori gastritis in mice. J
Immunol. 2001;166:7456–61.
41. Zhao X, Wang Q, Qian Y, Song JL,. Ilex kudingcha C.J. Tseng
(Kudingcha)
prevents
HCl/ethanol-induced
gastric
injury
in
Sprague-Dawley rats. Molecular Medicine Reports. 2013;7:1613-6.
42. Tanigawa T, Watanabe T, Higuchi K, Machida H, Okazaki H, Yamagami
H, Watanabe K, Tominaga K, Fujiwara Y, Oshitani N, et al: Lansoprazole,
a Proton Pump Inhibitor, Suppresses Production of Tumor Necrosis
Factoralpha and Interleukin-1beta Induced by Lipopolysaccharide and
Helicobacter Pylori Bacterial Components in Human Monocytic Cells via
Inhibition of Activation of Nuclear Factor-kappaB and Extracellular
Signal-Regulated Kinase. J Clin Biochem Nutr. 2009, 45(1):86–92.
43. Lee HJ, Han YM, Kim EH, Kim YJ, Hahm KB. A possible involvement of
Nrf2-mediated heme oxygenase-1 up-regulation in protective effect of the
proton pump inhibitor pantoprazole against indomethacin-induced gastric
damage in rats. BMC Gastroenterology. 2012;12:143.
44. Rakananurak N, Sallapant S, Prueksapanich P, Somanawat K, Klaikaew
N, Rerknimitr R, et al. Aloe vera Improved Gastric Injury on Nonsteroidal
Anti-Inflammatory
Drugs-Induced
Gastropathy
in
Rats.
Thai
J
Gastroenterol. 2013; 14(2):87-92.
45. Zhao X, Wang Q, Qian Y, Song JL,. Ilex kudingcha C.J. Tseng
(Kudingcha)
prevents
HCl/ethanol-induced
gastric
injury
in
Sprague-Dawley rats. Molecular Medicine Reports. 2013;7:1613-6.
46. Eamlamnam K, Patumraj S, Visedopas N, et al. Effects of Aloe vera and
sucralfate on gastric microcirculatory changes, cytokine levels and gastric
ulcer healing in rats. World J Gastroenterol. 2006;12:2034-9.
47. Naito Y, Yoshikawa T. Molecular and cellular mechanism involved in
Helicobacter pylori induced inflammation and oxidative stress. Free Rad
Biol and Med. 2002;33:323-6.
48. Jainu M, Devi CSS. Gastroprotective action of Cissus quadrangularis
extract against NSAID induced gastric ulcer: role of proinflammatory
cytokines and oxidative damage. Chem Biol Interact. 2006;161:262–70.
49. Konturek PC, Duda A, Brzozowski T, Konturek SJ, Kwiecien S,
Drozdowicz D, et al. Activation of genes for superoxide dismutase,
interleukin-1beta, tumor necrosis factor-alpha, and intercellular adhesion
molecule-1 during healing of ischemia-reperfusion-induced gastric injury.
Scand J Gastroenterol. 2000;35(5):452-63.
50. Fox JG, Megraud F. Helicobacter. In: Murray PR, editor. Manual of
clinical microbiology. 9th ed. Pensylvania: Elsevier Mosby; 2007.
hlm.947-62.
51. Israel DA, Peek RM. Review article: Pathogenesis of Helicobacter pyloriinduced gastric inflammation. Aliment Pharmacol Ther. 2001;15:1271-90.
52. Bodger K, Crabtree JE. Helicobacter pylori and gastric inflammation.
British Med Bull. 1998;54:139-50.
53. Banerjee A, Mukhopadhyay AK, Paul S, Bhattacharyya A and Swarnakar
S. Unveiling the Intricacies of Helicobacter pylori-induced Gastric
Inflammation: T Helper cells and Matrix Metalloproteinases at a
Crossroad. In: Mozsik G, editor. Current Topics in Gastritis. Croatia:
InTech Publishers; 2013. Chapter 7.
54. Furuta T, El-Omar EM, Xiao F, Shirai N, Takashima M, Sugimura H.
Interleukin 1beta polymorphisms increase risk of hypochlorhydria and
atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan.
Gastroenterology. 2002;123(1):92-105.
55. Schottelius AJ, Mayo MW, Sartor RB, Baldwin AS. Interleukin-10
signaling blocks inhibitor of kappaB kinase activity and nuclear factor
kappaB DNA binding. J Biol Chem. 1999;274:31868-74.
56. Al-Ashy R, Chakroun I, El-Sabban ME, Homaidan FR. The role of NFkappaB in mediating the anti-inflammatory effects of IL-10 in intestinal
epithelial cells. Cytokine. 2006; 36:1-8.
57. Luster AD. Chemokines-chemotactic cytokines that mediate inflammation.
N Engl J Med. 1998;338:436-45.
58. Yamada H, Aihara T, Okabe S. Mechanism for Helicobacter pylori
stimulation of interleukin-8 production in a gastric epithelial cell line
(MKN 28): roles of mitogen-activated protein kinase and interleukin1beta. Biochem Pharmacol. 2001;61:1595-604.
59. Kim H, Lim JW, Kim KH. Helicobacter pylori-induced expression of
interleukin-8 and cyclooxygenase-2 in AGS gastric epithelial cells:
mediation by nuclear factor-kappaB. Scand J Gastroenterol. 2001;36:70616.
60. Seo JH, Lim JW, Kim H, Kim KH. Helicobacter pylori in a Korean isolate
activates mitogen-activated protein kinases, AP-1, and NF-kappaB and
induces chemokine expression in gastric epithelial AGS cells. Lab Invest.
2004;84:49-62.
61. Robinson K, Kenefeck R, Pidgeon E, Shakib S, Patel S, Polson R, et al.
Helicobacter pylori-induced peptic ulcer disease is associated with
inadequate regulatory T-cell responses. Gut. 2008;57:1375-85.
62. Chu SH, Kim H, Seo JY, Lim JW, Mukaida N, Kim KH. Role of NFkappaB and AP-1 on Helicobater pylori-induced IL-8 expression in AGS
cells. Dig Dis Sci. 2003; 48:257-65.
63. Rani HAA, Fauzi A. Infeksi Helicobacter pylori. In: Sudoyo AW,
Setiyohadi B, editor. Buku Ajar Penyakit Dalam. 6th ed. Jakarta: Penyakit
Dalam Fakultas Kedokteran Universitas Indonesia: 2014. P925-9
64. Montemurro P, Nishioka H, Dundon WG, de Bernard M, Del Giudice G,
Rappuoli R, et al. The neutrophil-activating protein (HP-NAP) of
Helicobacter pylori is a potent stimulant of mast cells. Eur J Immunol.
2002;32:671-6.
65. Sander GB, Mazzoleni LE, Francesconi CF, Wortmann AC, Ott EA, Theil
A, et al. Development and validation of a cross-cultural questionnaire to
evaluate nonulcer dyspepsia: The Porto Alegre Dyspeptic Symptoms
Questionnaire (PADYQ). Dig Dis Sci. 2004, 49(11):1822-9.
66. Crabtree JE, Covacci A, Farmery SM. Helicobacter pylori induced
interleukin-8 expression in gastric epithelial cells is associated with CagA
positive phenotype. J Clin Pathol. 1995;48:41-5.
67. Sumadi IK. Hubungan Infeksi Helicobacter pylori dengan kadar
pepsinogen II serum penderita dyspepsia ( Tesis ). Universitas udayana:
2005
68. Bode G, Rothenbacher D, Brenner H, Adler G. Helicobacter pylori and
abdominal symptoms: a population-based study among preschool children
in southern Germany. Pediatrics 1998;101:634-7.
69. Hirlan, Gastritis dalam Buku Ajar Ilmu Penyakit Dalam Edisi 5, Internal
Publishing : 2009 ; 509-512.
70. Joshi A, Gupta SD, Ahuja V, Sharma MP. Symptom score does not
correlate with gastritis grade and Helicobacter pylori infection in non ulcer
dyspepsia. Trop Gastroenterol 2001;22:194-6.
71. Kasifoglu N, Akgun Y, Saricam T, Kiremitci A, Tercan. IL-8 Serum level
in patients with Helicobacter pylori infection and relation between
serological markers. African Journal of Microbiology 2009 ;11:822-25.
72. Khudhur S, Karhoot J, Khafi AJ, Mohsin J. Increase serum IL-8 level in
Iragi patients with Helicobacter pylori Cag A genotype infection. The Iraqi
Postgruate Meddical Journal 2011 Vol.10.
73. Pandeya N, Whiteman DC, Australian Cancer Study. Prevalence and
determinants of Helicobacter pylori sero-positif in the Australian adult
community. J Gastroenterology Hepatology.2011;Aug;26(8);1283-9
1. El-Zimaity HMT. Recent advances in the histopathology of gastritis.
Current Diagnostic Pathology: 2007; 13:340-8.
2. Rugge M, Genta RM. Staging and grading of chronic gastritis. Human
pathology: 2005; 36:228-33.
3. Fox JG, Wang TC. Inflammation, atrophy and gastric cancer. The Journal
of Clinical Investigation: 2007; 17:60-9.
4. Cesar ACG, Cury PM, Payao SLM. Comparison of histological and
molecular diagnosis of Helicobacter pylori in benign lesions and gastric
adenocarcinoma. Braz J Microbiol: 2005; 36(1):261-6.
5. Rehnberg-Laiho L, Rautelin H, Koskela P, Sarna S, Pukkala E, Aromaa A,
et al. Decreasing prevalence of helicobacter antibodies in Finland, with
reference to the decreasing incidence of gastric cancer. Epidemiol Infect:
2001; 126:37-42.
6. Matsukura N, Yamada S, Kato S, Tomtitchong P, Tajiri T, Miki M, et al.
Genetic differences in interleukin-1 betapolymorphisms among four Asian
populations: an analysis of the Asian paradox between H. pylori infection
and gastric cancer incidence. J Exp Clin Cancer Res: 2003; 22: 47-55.
7. Xuan J, Deguchi R, Yanagi H, Ozawa H, Urano T, Ogawa Y, et al.
Relationship between gastric mucosal IL-8 levels and histological gastritis
in patients with Helicobacter pylori infection. Tokai J Exp Clin Med:
2005; 30(2):83-8.
8. Andersen LP, Holck S, Janulaityte-Gu¨nther D, Kupcinskas L, Kiudelis G,
Jonaitis L, et al. Gastric inflammatory markers and interleukins in patients
with functional dyspepsia, with and without Helicobacter pylori infection.
FEMS Immunology and Medical Microbiology: 2005; 44:233–8.
9. Toljamo K. Gastric erosions – clinical significance and pathology. A longterm follow-up study. University of Oulu, Finland:Acta Univ Oul: 2012:
hlm 1-80.
10. S. Ilyas. Repository. Usu.ac.id 2013
11. Dixon MF, Genta RM, Yardley H, Correa P. Classification and grading of
gastritis: the updated Sydney system. Am J Surg Pathol. 1996;20:1161–81.
12. Aydin O, Egilmez R, Karabacak T, Kanik A. Interobserver variation in
histopathological assessment of Helicobacter pylori gastritis.World J
Gastroenterol. 2003; 9: 2232-5.
13. Szoke D. Genetic factors related to the histological and macroscopic
lesions of the stomach. [disertasi]. Budapest: Semmelweis University;
2009. Hlm 7-61.
14. Guindy AE, Ghoraba H. A study of the concordance between endoscopic
gastritis and histological gastritis in nonulcer dyspeptic patients with and
without Helicobacter pylori infection. Tanta Medical Sciences Journal.
2007;2(2):67-82.
15. Adibi
P.
Gastritis.
[Diunduh
19
Mei
2014].
Tersedia
dari:
http://med.mui.ac.ir
16. Wehbi M, Acute gastritis Medscape. 2014
17. Simadibrata M. Dyspepsia and Gastroesophageal Reflux Disease (GERD):
Is There Any Correlation? Acta Med Indones. 2009; 41(4): 222-7.
18. Silva MIG, de Sousa FCF. Gastric ulcer etiology. In: Chai J, editor. Peptic
Ulcer Disease. Shanghai: Intech; 2011. hlm. 3-28.
19. Loyd RA, McClellan DA. Update on the evaluation and management of
functional dyspepsia. Am Fam Physician. 2011;83(5):547-52.
20. Mueller A, Merrel DS, Grimm J, Falkow S. Profiling of microdissected
gastric epithelial cells reveals a cell-type specific response to Helicobacter
pylori infection. Gastroenterology. 2004;127:1446–62.
21. Syam AF, Sadikin M, Wanandi SI, Rani AA. Molecular mechanism on
healing process of peptic ulcer. Acta Med Indones. 2009;41(2):95-8.
22. Brzozowski T, Konturek PC, Konturek SJ, Brzozowska I, Pawlik T. Role
of prostaglandins in gastroprotection and gastric adaptation. Journal of
physiology and pharmacology. 2005; 56(Suppl 3):33-55.
23. Blaser MJ. Who are we? Indigenous microbes and the ecology of human
disease. EMBO Reports. 2006;7(10): 956–60.
24. Fischer W, Puls J, Buhrdorf R, Gebert B, Odenbreit S, Haas R. Systematic
mutagenesis of the Helicobacter pylori cag pathogenicity island: essential
genes for CagA translocation in host cells and induction of interleukin-8.
Mol Microbiol. 2001; 42:1337-48.
25. Holck S, Norgaard A, Bennedsen M, Permin H, Norn S, Andersen LP, et
al. Gastric mucosal cytokine responses in Helicobacter pylori-infected
patients with gastritis and peptic ulcers. Association with inflammatory
parameters and bacteria load. FEMS Immunology and Medical
Microbiology. 2003;36:175-80.
26. Farinati F, Cardin R, Russo VM, Busatto G, Franco M, Rugge M.
Helicobacter pylori CagA status, mucosal oxidative damage and gastritis
phenotype: a potential pathway to cancer? Helicobacter. 2003; 8:227-34.
27. Farinati F, Cardin R, Russo VM, Busatto G, Franco M, Rugge M.
Helicobacter pylori CagA status, mucosal oxidative damage and gastritis
phenotype: a potential pathway to cancer? Helicobacter. 2003; 8:227-34.
28. Kusters JG, van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter
pylori infection. Clin Microbiol Rev. 2006; 19:449-90.
29. Pelicic V, Reyrat JM, Sartori L, Pagliaccia C, Rappuoli R, Telford JL, et
al.
Helicobacter pylori VacA cytotoxin associated with the bacteria
increases epithelial permeability independently of its vacuolating activity.
Microbiology. 1999;145(8): 2043-50.
30. Sundrud MS, Torres VJ, Unutmaz D, Cover TL. Inhibition of primary
human T cell proliferation by Helicobacter pylori vacuolating toxin
(VacA) is independent of VacA effects on IL-2 secretion. Proc Natl Acad
Sci U S A. 2004;101:7727-32.
31. Zhang Z, Zheng Q, Chen X, Xiao S, Liu W, Lu H. The Helicobacter
pylori duodenal ulcer promoting gene, dupA in China. BMC
Gastroenterol. 2008;8:49-54.
32. Lu H, Hsu PI, Graham DY, Yamaoka Y. Duodenal ulcer promoting gene
of Helicobacter pylori. Gastroenterology. 2005;128:833-48.
33. Yamaoka Y, Kodama T, Kita M, Imanishi J, Kashima K, Graham DY.
Relation between cytokines and Helicobacter pylori in gastric cancer.
Helicobacter. 2001;6(2):116-24.
34. Rad R, Gerhard M, Lang R, Schoniger M, Rosch T, Schepp W, et al. The
Helicobacter pylori blood group antigen-binding adhesin facilitates
bacterial colonization and augments a nonspecific immune response. J
Immunol. 2002;168: 3033-41.
35. Montecucco C, de Bernard M. Molecular and cellular mechanisms of
action of the vacuolating cytotoxin (VacA) and neutrophil-activating
protein (HP-NAP) virulence factors of Helicobacter pylori. Microbes
Infect. 2003;5:715-21.
36. Banerjee A, Mukhopadhyay AK, Paul S, Bhattacharyya A and Swarnakar
S. Unveiling the Intricacies of Helicobacter pylori-induced Gastric
Inflammation: T Helper cells and Matrix Metalloproteinases at a
Crossroad. In: Mozsik G, editor. Current Topics in Gastritis. Croatia:
InTech Publishers; 2013. Chapter 7.
37. Zakaria Z, Devaney RJ, Atherthon JC, Robinson K. Effects of interleukin10 on the gastric epithelial cell response to Helicobacter pylori. In 8th
International Workshop on Pathogenesis and Host Response in
Helicobacter Infections, 5th July, Helsingor, Denmark; 2008.hlm. HP-76.
38. Lew E. Peptic ulcer disease. In: Greenberger NJ, editor. Current Diagnosis
and Treatment Gastroenterology, Hepatology, and Endoscopy. New York:
McGraw Hill; 2009.hlm.175-83.
39. Farinati F, Cardin R, Russo VM, Busatto G, Franco M, Rugge M.
Helicobacter pylori CagA status, mucosal oxidative damage and gastritis
phenotype: a potential pathway to cancer? Helicobacter. 2003; 8:227-34.
40. Eaton KA, Mefford M, Thevenot T. The role of T cell subsets and
cytokines in the pathogenesis of Helicobacter pylori gastritis in mice. J
Immunol. 2001;166:7456–61.
41. Zhao X, Wang Q, Qian Y, Song JL,. Ilex kudingcha C.J. Tseng
(Kudingcha)
prevents
HCl/ethanol-induced
gastric
injury
in
Sprague-Dawley rats. Molecular Medicine Reports. 2013;7:1613-6.
42. Tanigawa T, Watanabe T, Higuchi K, Machida H, Okazaki H, Yamagami
H, Watanabe K, Tominaga K, Fujiwara Y, Oshitani N, et al: Lansoprazole,
a Proton Pump Inhibitor, Suppresses Production of Tumor Necrosis
Factoralpha and Interleukin-1beta Induced by Lipopolysaccharide and
Helicobacter Pylori Bacterial Components in Human Monocytic Cells via
Inhibition of Activation of Nuclear Factor-kappaB and Extracellular
Signal-Regulated Kinase. J Clin Biochem Nutr. 2009, 45(1):86–92.
43. Lee HJ, Han YM, Kim EH, Kim YJ, Hahm KB. A possible involvement of
Nrf2-mediated heme oxygenase-1 up-regulation in protective effect of the
proton pump inhibitor pantoprazole against indomethacin-induced gastric
damage in rats. BMC Gastroenterology. 2012;12:143.
44. Rakananurak N, Sallapant S, Prueksapanich P, Somanawat K, Klaikaew
N, Rerknimitr R, et al. Aloe vera Improved Gastric Injury on Nonsteroidal
Anti-Inflammatory
Drugs-Induced
Gastropathy
in
Rats.
Thai
J
Gastroenterol. 2013; 14(2):87-92.
45. Zhao X, Wang Q, Qian Y, Song JL,. Ilex kudingcha C.J. Tseng
(Kudingcha)
prevents
HCl/ethanol-induced
gastric
injury
in
Sprague-Dawley rats. Molecular Medicine Reports. 2013;7:1613-6.
46. Eamlamnam K, Patumraj S, Visedopas N, et al. Effects of Aloe vera and
sucralfate on gastric microcirculatory changes, cytokine levels and gastric
ulcer healing in rats. World J Gastroenterol. 2006;12:2034-9.
47. Naito Y, Yoshikawa T. Molecular and cellular mechanism involved in
Helicobacter pylori induced inflammation and oxidative stress. Free Rad
Biol and Med. 2002;33:323-6.
48. Jainu M, Devi CSS. Gastroprotective action of Cissus quadrangularis
extract against NSAID induced gastric ulcer: role of proinflammatory
cytokines and oxidative damage. Chem Biol Interact. 2006;161:262–70.
49. Konturek PC, Duda A, Brzozowski T, Konturek SJ, Kwiecien S,
Drozdowicz D, et al. Activation of genes for superoxide dismutase,
interleukin-1beta, tumor necrosis factor-alpha, and intercellular adhesion
molecule-1 during healing of ischemia-reperfusion-induced gastric injury.
Scand J Gastroenterol. 2000;35(5):452-63.
50. Fox JG, Megraud F. Helicobacter. In: Murray PR, editor. Manual of
clinical microbiology. 9th ed. Pensylvania: Elsevier Mosby; 2007.
hlm.947-62.
51. Israel DA, Peek RM. Review article: Pathogenesis of Helicobacter pyloriinduced gastric inflammation. Aliment Pharmacol Ther. 2001;15:1271-90.
52. Bodger K, Crabtree JE. Helicobacter pylori and gastric inflammation.
British Med Bull. 1998;54:139-50.
53. Banerjee A, Mukhopadhyay AK, Paul S, Bhattacharyya A and Swarnakar
S. Unveiling the Intricacies of Helicobacter pylori-induced Gastric
Inflammation: T Helper cells and Matrix Metalloproteinases at a
Crossroad. In: Mozsik G, editor. Current Topics in Gastritis. Croatia:
InTech Publishers; 2013. Chapter 7.
54. Furuta T, El-Omar EM, Xiao F, Shirai N, Takashima M, Sugimura H.
Interleukin 1beta polymorphisms increase risk of hypochlorhydria and
atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan.
Gastroenterology. 2002;123(1):92-105.
55. Schottelius AJ, Mayo MW, Sartor RB, Baldwin AS. Interleukin-10
signaling blocks inhibitor of kappaB kinase activity and nuclear factor
kappaB DNA binding. J Biol Chem. 1999;274:31868-74.
56. Al-Ashy R, Chakroun I, El-Sabban ME, Homaidan FR. The role of NFkappaB in mediating the anti-inflammatory effects of IL-10 in intestinal
epithelial cells. Cytokine. 2006; 36:1-8.
57. Luster AD. Chemokines-chemotactic cytokines that mediate inflammation.
N Engl J Med. 1998;338:436-45.
58. Yamada H, Aihara T, Okabe S. Mechanism for Helicobacter pylori
stimulation of interleukin-8 production in a gastric epithelial cell line
(MKN 28): roles of mitogen-activated protein kinase and interleukin1beta. Biochem Pharmacol. 2001;61:1595-604.
59. Kim H, Lim JW, Kim KH. Helicobacter pylori-induced expression of
interleukin-8 and cyclooxygenase-2 in AGS gastric epithelial cells:
mediation by nuclear factor-kappaB. Scand J Gastroenterol. 2001;36:70616.
60. Seo JH, Lim JW, Kim H, Kim KH. Helicobacter pylori in a Korean isolate
activates mitogen-activated protein kinases, AP-1, and NF-kappaB and
induces chemokine expression in gastric epithelial AGS cells. Lab Invest.
2004;84:49-62.
61. Robinson K, Kenefeck R, Pidgeon E, Shakib S, Patel S, Polson R, et al.
Helicobacter pylori-induced peptic ulcer disease is associated with
inadequate regulatory T-cell responses. Gut. 2008;57:1375-85.
62. Chu SH, Kim H, Seo JY, Lim JW, Mukaida N, Kim KH. Role of NFkappaB and AP-1 on Helicobater pylori-induced IL-8 expression in AGS
cells. Dig Dis Sci. 2003; 48:257-65.
63. Rani HAA, Fauzi A. Infeksi Helicobacter pylori. In: Sudoyo AW,
Setiyohadi B, editor. Buku Ajar Penyakit Dalam. 6th ed. Jakarta: Penyakit
Dalam Fakultas Kedokteran Universitas Indonesia: 2014. P925-9
64. Montemurro P, Nishioka H, Dundon WG, de Bernard M, Del Giudice G,
Rappuoli R, et al. The neutrophil-activating protein (HP-NAP) of
Helicobacter pylori is a potent stimulant of mast cells. Eur J Immunol.
2002;32:671-6.
65. Sander GB, Mazzoleni LE, Francesconi CF, Wortmann AC, Ott EA, Theil
A, et al. Development and validation of a cross-cultural questionnaire to
evaluate nonulcer dyspepsia: The Porto Alegre Dyspeptic Symptoms
Questionnaire (PADYQ). Dig Dis Sci. 2004, 49(11):1822-9.
66. Crabtree JE, Covacci A, Farmery SM. Helicobacter pylori induced
interleukin-8 expression in gastric epithelial cells is associated with CagA
positive phenotype. J Clin Pathol. 1995;48:41-5.
67. Sumadi IK. Hubungan Infeksi Helicobacter pylori dengan kadar
pepsinogen II serum penderita dyspepsia ( Tesis ). Universitas udayana:
2005
68. Bode G, Rothenbacher D, Brenner H, Adler G. Helicobacter pylori and
abdominal symptoms: a population-based study among preschool children
in southern Germany. Pediatrics 1998;101:634-7.
69. Hirlan, Gastritis dalam Buku Ajar Ilmu Penyakit Dalam Edisi 5, Internal
Publishing : 2009 ; 509-512.
70. Joshi A, Gupta SD, Ahuja V, Sharma MP. Symptom score does not
correlate with gastritis grade and Helicobacter pylori infection in non ulcer
dyspepsia. Trop Gastroenterol 2001;22:194-6.
71. Kasifoglu N, Akgun Y, Saricam T, Kiremitci A, Tercan. IL-8 Serum level
in patients with Helicobacter pylori infection and relation between
serological markers. African Journal of Microbiology 2009 ;11:822-25.
72. Khudhur S, Karhoot J, Khafi AJ, Mohsin J. Increase serum IL-8 level in
Iragi patients with Helicobacter pylori Cag A genotype infection. The Iraqi
Postgruate Meddical Journal 2011 Vol.10.
73. Pandeya N, Whiteman DC, Australian Cancer Study. Prevalence and
determinants of Helicobacter pylori sero-positif in the Australian adult
community. J Gastroenterology Hepatology.2011;Aug;26(8);1283-9